To investigate the diagnostic efficiency of TP73‐AS1 and CRNDE in distinguishing NSCLC from BLD, an additional cohort of plasma specimens from 62 NSCLC patients, 60 patients with COPD, and 46 patients with pneumonia was utilized as an extension set. Here, TP73 is linked to non-small cell lung carcinoma.